Solid-phase organic synthesis (SPOS) of modulators of estrogenic and androgenic action

Mini-Reviews in Medicinal Chemistry

Volumn 6, Issue 1, 2006, Pages 37-52

  Poirier, Donald ^a   Maltais, René ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acylation; Diversification; Hydroxysteroids; Nuclear estrogen receptors; Polymer bound glycerol; Sulfotransferase

Indexed keywords

ANASTROZOLE; ANDROGEN; ANDROGEN RECEPTOR; ANDROGEN RECEPTOR MODULATOR; ANDROSTANOLONE; ANDROSTERONE DERIVATIVE; ANTIANDROGEN; ANTIESTROGEN; BICALUTAMIDE; CELL NUCLEUS RECEPTOR; ENZYME INHIBITOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; FLUTAMIDE; GONADORELIN AGONIST; HORMONE RECEPTOR STIMULATING AGENT; NILUTAMIDE; PEPTIDE DERIVATIVE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; STERYL SULFATASE; STERYL SULFATASE INHIBITOR; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; HYDROXYSTEROID DEHYDROGENASE;

ACYLATION; ALOPECIA; ANTINEOPLASTIC ACTIVITY; BREAST TUMOR; CATALYSIS; CLINICAL PROTOCOL; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENDOCRINE DISEASE; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; IC 50; MENOPAUSE; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SOLID PHASE SYNTHESIS; STEROIDOGENESIS; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM; METHODOLOGY; SYNTHESIS;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROGEN ANTAGONISTS; COMBINATORIAL CHEMISTRY TECHNIQUES; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; HUMANS; MOLECULAR STRUCTURE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; STERYL-SULFATASE;

EID: 33644906407     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706775197802     Document Type: Review

References (105)

1. Milgrom, E. Steroid Hormones. In Hormones: From molecules to disease; Baulieu, E.E.; Kelly, P.A. Ed.; Hermann, publishers in arts and science: Paris, 1990; pp. 385-437.
2. Payne, A.H.; Hales, D.B. Endocrine Rev., 2004, 25, 947-970.
3. Labrie, F. Mol. Cell. Endocrinol., 1991, 78, C113-C118.
4. Labrie, F.; Luu-The, V.; Lin, SX; Slmard, J.; Labrie, C.; El-Alfy, M.; Pelletier, G.; Bélanger, A. J. Mol. Endocrinol., 2000, 25, 1-16.
5. Labrie, F.; Luu.-The, V.; Labrie, C.; Bélanger, A.; Simard, J.; Lin, S.X; Pelletier, G. Endocrine Rev., 2003, 24, 152-182.
6. von Angerer, E. The estrogen receptor as a target for rational drug design. In Molecular Biology Intelligence Unit, Landes, R.G. Company: Austin, TX, 1995.
7. Anstead, G.M.; Carlson, K.E.; Katzenellenbogen, J.A. Steroids, 1997, 62, 268-303.
8. White, R.; Parker, M.G. Endocr. Relat. Cancer, 1998, 5, 1-14.
9. Mcewen, B.S.; Alves, S.E. Endocrine Rev., 1999, 20, 279-307.
10. Khosla, S.; Bilezikian, J.P. Endocrinol. Metab. Clin. N. Am., 2003, 32, 195-218.
11. Jordan, V.C.; Murphy, C.S. Endocrine Rev., 1990, 11, 578-610.
12. Magarian, R.A.; Overacre, L.B.; Singh, S.; Meyer, K.L. Curr. Med. Chem., 1994, 1, 61-104.
13. Howell, A. Oncology, 1997, 11, 59-64.
14. Katzenellenbogen, B.S.; Montano, M.M.; Ekena, K.; Herman, M.E.; McInerney, E.M. Breast Cancer Res. Treat, 1997, 44, 23-38.
15. MacGregor, J.I; Jordan, V.C. Pharmacol. Rev., 1998, 50, 151-196.
16. Curtis, M.G. J. Womens Health, 1999, 8, 321-333.
17. Wakeling, A.E. Endocr. Relat. Cancer, 2000, 7, 17-28.
18. Jordan, V.C. J. Med. Chem., 2003, 46, 1081-1111.
19. Negro-Vilar, A. J. Clin. Endocrinol. Metab., 1999, 84, 3459-3462.
20. Singh, S.M.; Gauthier, S.; Labrie, F. Curr. Med. Chem., 2000, 7, 211-247.
21. Raudrant, D.; Rabe, T. Drugs, 2003, 63, 463-492.
22. Bratoeff, E.; Ramirez, E.; Murillo, E.; Flores, G.; Cabeza, M. Curr. Med. Chem., 1999, 6, 1107-1123.
23. Hobkirk, R. Trends Endocr. Metab., 1993, 4, 69-79.
24. Poirier, D.; Ciobanu, L.C.; Maltais, R. Exp. Opin. Ther. Patents, 1999, 9, 1083-1099.
25. Smith, H.J.; Nicholls, P.J.; Simons, C.; Le Lain, R. Exp. Opin. Ther. Patents, 2001, 11, 789-824.
26. Ahmed, S.; Owen, C.P.; James, K.; Sampson, L.; Patel, C.K. Curr. Med. Chem, 2002, 9, 263-273.
27. Nussbaumer, P.; Billich, A. Exp. Opin. Ther. Patents, 2003, 13, 605-625.
28. Hanson, S.R.; Best, M.D.; Wong, C.H. Angew. Chem. Int. Ed., 2004, 43, 5736-5763.
29. Winum, J.Y.; Scozzafava, A.; Montero, J.L.; Supuran, C.T. Med. Res. Rev., 2005, 25, 186-225.
30. Reed, M.J.; Purohit, A.; Woo, L.W.L.; Newman, S.P.; Potter, B.V.L. Endocrine Rev., 2005, 26, 171-202.
31. Howarth, N.M.; Purohit, A.; Reed, M.J. J. Med. Chem., 1994, 37, 219-221.
32. Boivin, R.P.; Luu-The, V.; Lachance, R.; Labrie, F.; Poirier, D. J. Med. Chem., 2000, 43, 4465-4478.
33. Ciobanu, L.C.; Maltais, R.; Poirier, D. Org. Lett., 2000, 2, 445-448.
34. Poirier, D.; Bérubé, M.; Fournier, D. In Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries; Roger Epton, Ed.; Mayflower Worldwide Limited: Kingswinford, 2004; pp. 281-285.
35. Ciobanu, L.C.; Poirier, D. J. Comb. Chem., 2003, 5, 429-440.
36. Poirier, D.; Ciobanu, L.C.; Bérubé, M. Bioorg. Med. Chem. Lett., 2002, 12, 2833-2838.
37. Ciobanu, L.C. In Synthèse chimique en solution et sur support solide d'inhibiteurs de la stéroïde sulfatase. PhD Thesis of Université Laval, Québec, Canada, 2003; pp. 188-218.
38. Penning, T.M.; Ricigliano, J.W. J. Enz. Inh., 1991, 5, 165-198.
39. Labrie, F.; Luu-The, V.; Lin, S.X; Labrie, C.; Simard, J.; Breton, R.; Bélanger, A. Steroids, 1997, 62, 148-158.
40. Labrie, F.; Luu-The, V.; Lin, S.X; Simard, J.; Labrie, C. Trends Endocr. Metab., 2000, 11, 421-427.
41. Peltoketo, H.; Luu-The, V.; Simard, J.; Adamski, J. J. Mol. Endocrinol., 1999, 23, 1-11.
42. Adamski, J.; Jakob, F.J. Mot Cell. Endocrinol, 2001, 171, 14.
43. Mindnich, R.; Moller, G.; Adamski, J. Mol. Cell. Endocrinol, 2004, 218, 7-20.
44. Luu-The, V.; Zhang, Y.; Poirier, D.; Labrie, F. J. Steroid Biochem. Mol. Biol., 1995, 55, 581-587.
45. Luu-The, V. J. Steroid Biochem. Mol. Biol., 2001, 76, 143-151.
46. Penning, T.M. Endocr. Relat. Cancer, 1996, 3, 41-56.
47. Tremblay, M.R.; Poirier, D. J. Steroid Biochem. Mol. Biol., 1998, 66, 179-191.
48. Poirier, D.; Bydal, P.; Tremblay, M.R.; Sam, K.M.; Luu-The, V. Mol. Cell. Endocrinol, 2001, 171, 119-128.
49. Poirier, D. Curr. Med. Chem., 2003, 10, 453-457.
50. Tremblay, M.R.; Poirier, D. J. Comb. Chem., 2000, 2, 48-65.
51. Tremblay, M.R.; Poirier, D. Tetrahedron Lett., 1999, 40, 1277-1280.
52. Qiu, W.; Campbell, R.L.; Gangloff, A.; Dupuis, P.; Boivin, R.P.; Tremblay, M.R.; Poirier, D.; Lin, S.X. FASEB J., 2002, 16, 1829-1831.
53. Bérubé, M.; Poirier, D. Org. Lett., 2004, 6, 3127-3130.
54. Lawrence, H.R.; Vicker, N.; Allan, G.M.; Smith, A.; Mahon, M.F.; Tutill, H.J.; Purohit, A.; Reed, M.J.; Potter, B.V.L. J. Med. Chem., 2005, 48, 2759-2762.
55. Maltais, R.; Luu-The, V.; Poirier, D. Bioorg, Med. Chem., 2001, 9, 3101-3111.
56. Maltais, R.; Bérubé, M.; Marion, O.; Labrecque, R.; Poirier, D. Tetrahedron Lett., 2000, 41, 1691-1694.
57. Maltais, R.; Tremblay, M.R.; Poirier, D. J. Comb. Chem., 2000, 2, 604-614.
58. Li, X.; Chen, C.; Singh, S.M.; Labrie, F. Steroids, 1995, 60, 430-441.
59. Frye, S.V. Curr. Pharm. Des., 1996, 2, 59-84.
60. McConnell, J.; Stoner, E. Adv. Protein Chem., 2001, 56, 143-180.
61. Lombardi, P. Curr. Pharm. Des., 1995, 1, 23-50.
62. Hamilton, A.; Piccart, M. Ann. Oncol., 1999, 10, 377-384.
63. Santen, R.J.; Harvey, H.A. Endocr. Relat. Cancer, 1999, 6, 75-92.
64. Brodie, A.M.H.; Njar, V.C.O. Steroids, 2000, 65, 171-179.
65. Goss, P.E.; Strasser, K. J. Clin. Oncol., 2001, 19, 881-894.
66. Brueggemeier, R.W. Breast Cancer Res. Treat., 2002, 741, 177-185.
67. Santen, R.J. Steroids, 2003, 68, 559-567.
68. Miller, W.; Jackson, J. Exp. Opin. Invest. Drugs, 2003, 12, 337-351.
69. Bowler, J.; Lilley, T.J.; Pittam, J.D.; Wakeling, A.E. Steroids, 1989, 54, 71-99.
70. Tremblay, M.R.; Simard, J.; Poirier, D. Bioorg. Med. Chem. Lett, 1999, 9, 2827-2832.
71. Lee, C.Y.; Hanson, R.N. Tetrahedron, 2000, 56, 1623-1629.
72. Hanson, R.N.; Lee, C.Y; Friel, C.; Hughes, A.; DeSombre, E.R. Steroids, 2003, 68, 143-148.
73. Hanson, R.N.; Lee, C.Y.; Friel, C.J.; Dilis, R.; Hughes, A.; DeSombre, E.R. J. Med. Chem., 2003, 46, 2865-2876.
74. Arterburn, J.B.; Rao, K.V; Perry, M.C. Angew. Chem., Int. Ed., 2000, 39, 771-772.
75. Williard R.; Jammalamadaka. V.; Zava D.; Benz C.C.; Hunt C.A.; Kushner P.J.; Scanlan T.S. Chem. Biol, 1995, 2, 45-51.
76. Stauffer S.R.; Katzenellenbogen J.A. J. Comb. Chem., 2000, 2, 318-329.
77. Katzenellenbogen, J.A.; Katzenellenbogen, B.S.; Fink, B.E.; Stauffer, S.R.; Mortensen, D.S.; Sattigeri, V.J.; Huang, Y. (Board of Trustees of the University of Illinois, USA). PCT/US99/22747 (Published as WO 2000/ 019994).
78. Fink, B.E; Mortensen, D.S.; Stauffer, S.R.; Aron, Z.D.; Katzenellenbogen, J.A. Chem. Biol, 1999, 6, 205-219.
79. Smith, R.A.; Chen, J.; Mader, M.M.; Muegge, I; Moehler, U.; Katti, S.; Marrero, D.; Stirtan, W.G.; Weaver, D.R.; Xiao, H.; Carley, W. Bioorg. Med. Chem. Lett., 2002, 12, 2875-2878.
80. Chiu, C.; Tang, Z.; Ellingboe, J.W. (American Home Products Corporation, USA). PCT/US98/26363 (Published as WO 1999/32447).
81. Brown, S.D.; Armstrong, R.W. J. Org. Chem., 1997, 62, 7076-7077.
82. Defreest, L.A.; Mesfin, F.B.; Joseph, L.; McLeod, D.J.; Stallmer, A.; Reddy, S.; Balulad, S.S.; Jacobson, H.I.; Andersen, T.T.; Bennett, J.A. J. Peptide Res., 2004, 63, 409-419.
83. Mesfin, F.B.; Andersen, T.T.; Jacobson, H.I.; Zhu, S.; Bennett, J.A. J. Peptide Res., 2004, 58, 246-256.
84. Jacobson, H.I.; Bennet, J.A.; Mizejewski, G.J. Cancer Res., 1990, 50, 415-420.
85. Kasher, R.; Gayer, B.; Kulik, T.; Somjen, D.; Venkatesh, N.; Fridkin, M.; Katchalski-Katzir, E.; Kohen, F. Biopolymers (Pept. Sci.), 2004, 76, 404-420.
86. Sack. J.S.; Kish, K.F.; Wang, C.; Attar, R.M.; Kiefer, S.E.; An, Y.; Wu, G.Y.; Scheffler, J.E.; Salvati, M.E.; Krystek, S.R.; Weinmann, R.; Einspahr, H.M. Proc. Natl. Acad. Sci. USA, 2001, 98, 4904-4909.
87. Matias, P.M.; Donner, P.; Coelho, R.; Thomaz, M.; Peixoto, C.; Macedo, S.; Otto, N.; Joschko, S.; Scholz, P.; Wegg, A.; Bäsler, S.; Schäfer, M.; Egner, U.; Carrondo, M.A. J. Biol. Chem., 2000, 275, 26164-26171.
88. Labrie, F.; Bélanger, A.; Cusan, L.; Labrie, C.; Simard, J.; Luu-The, V.; Diamond, P.; Gomez, J.L.; Candas, B. Endocr. Relat. Cancer, 1996, 3, 243-278.
89. Maltais, R.; Mercier, C.; Labrie, F.; Poirier, D. Mol. Divers., 2005, 9, 67-79.
90. Lamothe, M.; Lannuzel, M.; Perez, M. J., Comb. Chem., 2002, 4, 73-78.
91. Meusel, M.; Gutschow, M. Org. Prep. Proc. Int., 2004, 36, 391-443.
92. Jung, G. Combinatorial peptide and norpeptide libraries, VCH: New York, USA, 1996.
93. Wilson, S.R.; Čzarnik, A.W. Combinatorial chemistry. Synthesis and application, John Wiley & Sons, Inc: New York, USA, 1997.
94. Bunin, B.A. The combinatorial index, Academic Press: New York, USA, 1998
95. Hall, D.G.; Manku, S.; Wang, F. J. Comb. Chem., 2001, 3, 1-27.
96. Maltais, R.; Tremblay, M.R.; Ciobanu, L.C.; Poirier, D. J. Comb. Chem., 2004, 6, 443-456.
97. Dolle, R.E. J. Comb. Chem., 2004, 6, 623-679.
98. Schreiber, S.L. Science, 2000, 287, 1964-1969.
99. Liao, Y.; Hu, Y.; Wu, J.; Zhu, Q.; Donavan, M.; Fathi, R.; Yang, Z. Curr. Med. Chem., 2003, 10, 2285-23-16.
100. Burke, M.D.; Schreiber, S.L. Angew. Chem. Int. Ed., 2004, 43, 46-58.
101. Nefzi, A.; Ostresh, J.M.; Yu., J.; Houghten, R.A. J. Org. Chem., 2004, 69, 3603-3609.
102. Lehn, J-M. Chem. Eur. J., 1999, 5, 2455-2463.
103. Cousins, G.R.L.; Poulsen, S-A.; Sanders, J.K.M. Curr. Opin. Chem. Biol, 2000, 4, 270-279.
104. Hoc, I; Nguyen, R. Comb. Chem. High Throughput Screen., 2001, 4, 53-74.
105. Corbett, A.D.; Cheeseman, J.D.; Kazlauskas, R.J.; Gleaso̧n, J.L. Angew. Chem. Int. Ed., 2004, 43, 2432-2436.